Bryan Montanelli
About Bryan Montanelli
Bryan Montanelli is a Senior Associate Scientist at Bristol Myers Squibb with over 15 years of experience in microbiology and biopharmaceuticals.
Title
Bryan Montanelli holds the position of Senior Associate Scientist at Bristol Myers Squibb in the United States. His current role follows previous positions at the same company, including Associate Research Scientist and Associate Scientist I.
Company
Bryan Montanelli is currently employed at Bristol Myers Squibb, where he serves as a Senior Associate Scientist. Bristol Myers Squibb is a renowned global biopharmaceutical company focused on the discovery, development, and delivery of innovative medicines for patients with serious diseases.
Education and Expertise
Bryan Montanelli earned a Bachelor of Science degree in Environmental Sciences with a focus on Biology from Rutgers, The State University of New Jersey-New Brunswick. He has over 15 years of experience in the fields of microbiology and biopharmaceuticals, offering substantial expertise in quality control microbiology and analytical biology.
Professional Background
Bryan Montanelli started his career at Schering-Plough as an Analytical Biologist in NJ Quality Laboratories Microbiology, where he worked from 2005 to 2007. He then joined Merck Research Laboratories as an Associate Scientist, working there for three years. His career later transitioned to roles in microbiology across several companies, including Integra Life Sciences and Laureate Biopharmaceutical Services, before taking on the position of Scientist III - QC Microbiology at Gallus BioPharmaceuticals. He has worked in various locations across New Jersey, including Princeton, Plainsboro, Union, Summit, and Kenilworth.
Achievements
Bryan Montanelli has a diverse professional background, including significant roles in quality control microbiology and analytical biology. He worked at Gallus BioPharmaceuticals as Scientist III - QC Microbiology and has held various scientist and microbiologist positions that showcase his extensive knowledge and experience in the industry. Notably, he was with Merck Research Laboratories during the transition period when Merck acquired Schering-Plough, indicating his adaptability and resilience during significant corporate changes.